Nxera Pharma Co., Ltd. (4565) Press Release
OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical Companies and Cloud and AI Infrastructure Technology Providers
Earlier from Nxera Pharma
- Nxera Pharma: Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
- Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026
- Nxera Pharma: Notice of Partial Forfeiture (Decrease in the Number of Shares to be Issued, etc.) in Connection with the Issuance of New Shares Under the RSU Plan
- Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing